Login to Your Account

Clinic Roundup

Wednesday, December 29, 2010
Sinovac Biotech Ltd., of Beijing, announced that it has received approval from the China State Food and Drug Administration to commence clinical trials for its inactivated EV71 vaccine against hand, foot and mouth disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription